Bringing p53 into the Clinic
The use of p53 as a biological marker to predict chemotherapeutic outcome
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
The use of p53 as a biological marker to predict chemotherapeutic outcome
membrane oxygenation (ECMO) support. Genetic analysis revealed compound heterozygous SCN5A loss-of-function and gain-offunction mutations, individually inherited from both his parents. In addition to the full spectrum
tumor cells. Transduction of downstream signaling is likely due to mutations self-activation (gain-offunction mutations) or to the involvement of new oncoprotein involved in the onset of tumorogenesis through
plays an important role in the development and survival of mast cells. Gain-offunction mutations in c-kit are one of the most characteristic events in mast cell leukemia
For authors and organisers
Find the right journal for your paper and submit your manuscript.